Repros Therapeutics Inc (RPRX)

[DewDiligence]

>I've already pointed out the irony that the guy whose tag line derides the efficent markets hypothesis - very reasonably in the small biotech space - should use a market move to justify a negative comment.)<

My observation about the requirement for an IND was based on my reading of the company’s Dec-3 PR and had nothing to do with the market reaction that day. However, I noted in the header of my post that the stock happened to be off 20%. If you thought the post in question was ironic, I would submit that you don’t understand the meaning of the word.

This is my last post on this particular matter.